Loading...


  • residency
  • He completed residency at Brady Urological Institute at the Johns Hopkins Hospital as a chief resident. (wikipedia.org)
  • He, then, moved to Chandigarh and worked at the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh as a resident, while pursuing the master's degree, passed MS with a bronze medal in 1973 and continued there to complete the senior residency in 1976. (wikipedia.org)
  • renal
  • In the modern era of targeted therapy, some patients with metastatic renal cell carcinoma may be able to forgo nephrectomy and be treated with sunitinib (Sutent) alone, according to results of the phase III CARMENA trial reported during the Plenary Session at the 2018 ASCO Annual Meeting.1 The. (ascopost.com)
  • Toni K. Choueiri, MD, and Lauren C. Harshman, MD, both of Dana-Farber Cancer Institute, discuss phase III study findings on perioperative nivolumab vs observation in patients with localized renal cell carcinoma undergoing nephrectomy (Abstract TPS4597). (ascopost.com)
  • Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, and Laurence Albiges, MD, PhD, of Gustave Roussy, discuss the implications of this study's potentially practice-changing finding that nephrectomy is no longer the standard of care for patients with metastatic renal cell carcinoma (Abstract LBA3). (ascopost.com)
  • Arnaud Méjean, MD, PhD, of the Hôpital Européen Georges Pompidou, discusses his study's potentially practice-changing finding that nephrectomy is no longer the standard of care for patients with metastatic renal cell carcinoma (Abstract LBA3). (ascopost.com)
  • Pfizer recently announced that the independent data monitoring committee for the phase III ATLAS trial, which is evaluating axitinib (Inlyta) as adjuvant therapy for patients at high risk of recurrent renal cell carcinoma (RCC) after nephrectomy, recommended stopping the trial at a planned interim. (ascopost.com)
  • medical
  • This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. (thefreedictionary.com)